Reproductive and Developmental Biology

The Korean Society of Animal Reproduction (한국동물번식학회)
권호 표지

Effects of BMI-1026, A Potent CDK Inhibitor, on Murine Oocyte Maturation and Metaphase II Arrest

  • Choi, Tae-Saeng (Department of Microbiology, College of Medicine, Dankook University)
  • Published : 2007.06.30
Download PDF
⟨ Previous Next ⟩

Abstract

Previous studies have shown that BMI-1026 is a potent inhibitor of the cyclin-dependent kinases (cdk). In cell culture, the compound also arrests G2/M strongly and G1/S and S weakly. Two key kinases, cdk1 (p34cdc2 kinase) and mitogen-activated protein (MAP) kinase (erk1 and 2), perform crucial roles during oocyte maturation and, later, metaphase II (MII) arrest. In mammalian oocytes, both kinases are activated gradually around the time of germinal vesicle breakdown (GVBD) and maintain high activity in eggs arrested at metaphase II. In this study, we examined the effects of BMI-1026 on GVBD and MII arrest in mouse oocytes. BMI-1026 inhibited GVBD of immature oocytes and activated MII-arrested oocytes in a concentration-dependent manner, with more than 90% of oocytes exhibiting GVBD inhibition and MII activation at 100 nM This is approximately 500$\sim$1,000 times more potent than the activity reported for the cdk inhibitors roscovitine (${\sim}50{\mu}M$) and butyrolactone (${\sim}100{\mu}M$). Based on the results of previous in vitro kinase assays, we expected BMI-1026 to inhibit only cdk1 activation in oocytes and eggs, not MAP kinase. However, in our cell-based system, it inhibited the activity of both kinases. We also found that the effect of BMI-1026 is reversible. Our results suggest that BMI-1026 inhibits GVBD and activates MII-arrested oocytes efficiently and reversibly and that it also inhibits both cdk1/histone HI kinase and MAP kinase in mouse oocytes.

Keywords

References

  1. Choi T, Aoki F, Mori M, Yamashita M, Nagahama Y, Kohmoto K (1991): Activation of p34$^{cdc2}$ protein kinase activity in meiotic and mitotic cell cycles in mouse oocytes and embryos. Development 113:789-795
  2. Choi T, Fukasawa K, Zhou R, Tessarollo L, Borror K, Resau J, Vande Woude GF (1996a): The Mos/mitogen-activated protein kinase (MAPK) pathway regulates the size and degradation of the first polar body in maturing mouse oocytes. Proc Natl Acad Sci USA 93:7032-7035
  3. Choi T, Rulong S, Resau J, Fukasawa K, Matten W, Kuriyama R, Mansour S, Ahn N, Vande Woude GF (1996b): Mos/mitogen-activated protein kinase can induce early meiotic phenotypes in the absence of maturation-promoting factor: a novel system for analyzing spindle formation during meiosis I. Proc Natl Acad Sci USA 93:4730-4735
  4. Hashimoto N, Watanabe N, Furuta Y, Tamemoto H, Sagata N, Yokoyama M, Okazaki K, Nagayoshi M, Takeda N, Ikawa Y (1994): Parthenogenetic activation of oocytes in c-mos-deficient mice. Nature 370: 68-71 https://doi.org/10.1038/370068a0
  5. Huo LJ, Fan HY, Zhong ZS, Chen DY, Schatten H, Sun QY (2004): Ubiquitin-proteasome pathway modulates mouse oocyte meiotic maturation and fertilization via regulation of MAPK cascade and cyclin B1 degradation. Mech Dev 121:1275-1287 https://doi.org/10.1016/j.mod.2004.05.007
  6. Ju JC, Tsay C, Ruan CW (2003): Alterations and reversibility in the chromatin cytoskeleton and development of pig oocytes treated with roscovitine. Mol Reprod Dev 64:482-491 https://doi.org/10.1002/mrd.10234
  7. Knockaert M, Lenormand P, Gray N, Schultz P, Pouyssegur J, Meijer L (2002): p42/44 MAPKs are intracellular targets of the CDK inhibitor purvalanol. Oncogene 21: 6413-6424 https://doi.org/10.1038/sj.onc.1205908
  8. Krischek C, Meinecke B (2001): Roscovitine, a specific inhibitor of cyclin-dependent protein kinases, reversibly inhibits chromatin condensation during in vitro maturation of porcine oocytes. Zygote 9:309-316 https://doi.org/10.1017/S0967199401001356
  9. Kubelka M, Anger M, Kalous J, Schultz R, Motlik J (2002a): Chromosome condensation pig oocytes: lack of a requirement for either cdc2 kinase or MAP. Mol Reprod Dev 63:110-118 https://doi.org/10.1002/mrd.10176
  10. Kubelka M, Anger M, Pavlok A, Kalous J, Schultz R, Motlik J (2002b): Activation of pig and cattle oocytes by butyrolactone I: morphological and biochemical study. Zygote 10:47-57 https://doi.org/10.1017/S0967199402002071
  11. Kubelka M, Motlik J, Schultz R, Pavlok A (2000): Butyrolactone I reversibly inhibits meiotic maturation of bovine oocytes without influencing chromosome condensation activity. Biol Reprod 62:292-302 https://doi.org/10.1095/biolreprod62.2.292
  12. Liu Lin, Ju JC, Yang X (1998): Differential inactivation of maturation-promoting factor and mitogen-activated protein kinase following parthenogenetic activation of bovine oocytes. Biol Reprod 59: 537-545 https://doi.org/10.1095/biolreprod59.3.537
  13. Maller JL, Schwab MS, Gross SD, Taieb FE, Roberts BT, Tunquist BJ (2002): The mechanism of CSF arrest in vertebrate oocytes. Mol Cell Endocrinol 187:173-178 https://doi.org/10.1016/S0303-7207(01)00695-5
  14. Meijer L, Borgne A, Mulner O, Chong JP, Blow JJ, Inagaki N, Inagaki M, Delcros JG, Moulinoux JP (1997): Biochemical and cellular effects of roscovitine, a potent and selective inhibitor of the cyclin-dependent kinases cdc2, cdk2, and cdk5. Eur J Biochem 243:527-536 https://doi.org/10.1111/j.1432-1033.1997.t01-2-00527.x
  15. Motlik J, Pavlok A, Kubelka M, Kalous J, Kalab P (1998): Interplay between cdc2 kinase and MAP kinase pathway during maturation of mammalian oocytes. Theriogenology 49:461-469 https://doi.org/10.1016/S0093-691X(97)00418-4
  16. Seong YS, Min C, Li L, Yang J, Kim Sy, Cao X, Kim K, Yuspa S, Chung HH, Lee K (2003): Characterization of a novel cyclin-dependent kinase 1 inhibitor, BMI-1026. Cancer Res 63:7384-7391
  17. Sobajima T, Aoki F, Kohmoto K (1993): Activation of mitogen-activated protein kinase during meiotic maturation in mouse oocytes. J Reprod Fertil 97: 389-394 https://doi.org/10.1530/jrf.0.0970389
  18. Verlhac MH, Kubiak J, Clarke H, Maro B (1994): Microtubule and chromatin behavior follow MAP kinase activity but not MPF activity during meiosis in mouse oocytes. Development 120:1017-1025
  19. Verlhac MH, Kubiak J, Weber M, Geraud G, Colledge WH, Evans MJ, Maro B (1996): Mos is required for MAP kinase activation and is involved in microtubule organization during meiotic maturation in the mouse. Development 122:815-822
  20. Vigneron C, Perreau C, Dalbles-Tran R, Joly C, Humblot P, Uzbekova S, Mermillod P (2004): Protein synthesis and mRNA storage in cattle oocytes maintained under meiotic block by roscovitine inhibition of MPF activity. Mol Reprod Dev 69:457-467 https://doi.org/10.1002/mrd.20172